These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26349054)

  • 1. Norovirus P particle: an excellent vaccine platform for antibody production against Alzheimer's disease.
    Fu L; Li Y; Hu Y; Yu B; Zhang H; Wu J; Wu H; Yu X; Kong W
    Immunol Lett; 2015 Nov; 168(1):22-30. PubMed ID: 26349054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Norovirus P particle-based active Aβ immunotherapy elicits sufficient immunogenicity and improves cognitive capacity in a mouse model of Alzheimer's disease.
    Fu L; Li Y; Hu Y; Zheng Y; Yu B; Zhang H; Wu J; Wu H; Yu X; Kong W
    Sci Rep; 2017 Jan; 7():41041. PubMed ID: 28106117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strikingly reduced amyloid burden and improved behavioral performance in Alzheimer's disease mice immunized with recombinant chimeric vaccines by hexavalent foldable Aβ₁₋₁₅ fused to toxin-derived carrier proteins.
    Yu YZ; Wang WB; Chen A; Chang Q; Liu S; Zhao M; Wang S; Qiu WY; Pang XB; Xu Q; Sun ZW
    J Alzheimers Dis; 2014; 41(1):243-60. PubMed ID: 24625800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of a novel method without sequence modification for developing NoV P particle-based chimeric vaccines.
    Li Y; Fu L; Hu Y; Jin H; Zheng Y; Yin Y; Wu H; Yu X; Kong W
    Protein Expr Purif; 2016 May; 121():73-80. PubMed ID: 26773744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing Th2 immune responses against amyloid protein by a DNA prime-adenovirus boost regimen for Alzheimer's disease.
    Kim HD; Jin JJ; Maxwell JA; Fukuchi K
    Immunol Lett; 2007 Sep; 112(1):30-8. PubMed ID: 17686533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active immunization with norovirus P particle-based amyloid-β chimeric protein vaccine induces high titers of anti-Aβ antibodies in mice.
    Yang P; Guo Y; Sun Y; Yu B; Zhang H; Wu J; Yu X; Wu H; Kong W
    BMC Immunol; 2019 Feb; 20(1):9. PubMed ID: 30755174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene vaccination to bias the immune response to amyloid-beta peptide as therapy for Alzheimer disease.
    Qu B; Rosenberg RN; Li L; Boyer PJ; Johnston SA
    Arch Neurol; 2004 Dec; 61(12):1859-64. PubMed ID: 15596606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short amyloid-beta (Abeta) immunogens reduce cerebral Abeta load and learning deficits in an Alzheimer's disease mouse model in the absence of an Abeta-specific cellular immune response.
    Maier M; Seabrook TJ; Lazo ND; Jiang L; Das P; Janus C; Lemere CA
    J Neurosci; 2006 May; 26(18):4717-28. PubMed ID: 16672644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abeta1-15 is less immunogenic than Abeta1-40/42 for intranasal immunization of wild-type mice but may be effective for "boosting".
    Leverone JF; Spooner ET; Lehman HK; Clements JD; Lemere CA
    Vaccine; 2003 May; 21(17-18):2197-206. PubMed ID: 12706711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel Aβ epitope vaccine based on bacterium-like particle against Alzheimer's disease.
    Fu L; Guo Y; Sun Y; Dong Y; Wu J; Yu B; Zhang H; Yu X; Wu H; Kong W
    Mol Immunol; 2018 Sep; 101():259-267. PubMed ID: 30029060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Aβ antibodies induced by Aβ-HBc virus-like particles prevent Aβ aggregation and protect PC12 cells against toxicity of Aβ1-40.
    Feng G; Wang W; Qian Y; Jin H
    J Neurosci Methods; 2013 Aug; 218(1):48-54. PubMed ID: 23701997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine efficacy of transcutaneous immunization with amyloid β using a dissolving microneedle array in a mouse model of Alzheimer's disease.
    Matsuo K; Okamoto H; Kawai Y; Quan YS; Kamiyama F; Hirobe S; Okada N; Nakagawa S
    J Neuroimmunol; 2014 Jan; 266(1-2):1-11. PubMed ID: 24315156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective DNA epitope chimeric vaccines for Alzheimer's disease using a toxin-derived carrier protein as a molecular adjuvant.
    Yu YZ; Wang S; Bai JY; Zhao M; Chen A; Wang WB; Chang Q; Liu S; Qiu WY; Pang XB; Xu Q; Sun ZW
    Clin Immunol; 2013 Oct; 149(1):11-24. PubMed ID: 23886550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-immunization with DNA and protein mixture: a safe and efficacious immunotherapeutic strategy for Alzheimer's disease in PDAPP mice.
    Liu S; Shi D; Wang HC; Yu YZ; Xu Q; Sun ZW
    Sci Rep; 2015 Jan; 5():7771. PubMed ID: 25586780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved synaptic and cognitive function in aged 3 × Tg-AD mice with reduced amyloid-β after immunotherapy with a novel recombinant 6Aβ15-TF chimeric vaccine.
    Yu YZ; Li QL; Wang HC; Liu S; Pang XB; Xu Q; Zhou XW; Huang PT
    Clin Immunol; 2018 Aug; 193():12-23. PubMed ID: 29803820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation Effects and Mechanisms of Different Adjuvants on a Norovirus P Particle-Based Active Amyloid-β Vaccine.
    Dai M; Feng X; Mo Z; Sun Y; Fu L; Zhang Y; Wu J; Yu B; Zhang H; Yu X; Wu H; Kong W
    J Alzheimers Dis; 2020; 77(4):1717-1732. PubMed ID: 32925038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a DNA Aβ42 vaccine in adult rhesus monkeys (Macaca mulatta): antibody kinetics and immune profile after intradermal immunization with full-length DNA Aβ42 trimer.
    Lambracht-Washington D; Fu M; Frost P; Rosenberg RN
    Alzheimers Res Ther; 2017 Apr; 9(1):30. PubMed ID: 28441965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active immunization of mice with an Abeta-Hsp70 vaccine.
    Koller MF; Mohajeri MH; Huber M; Wollmer MA; Roth Z'graggen BV; Sandmeier E; Moritz E; Tracy J; Nitsch RM; Christen P
    Neurodegener Dis; 2004; 1(1):20-8. PubMed ID: 16908970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus and virus-like particle-based immunogens for Alzheimer's disease induce antibody responses against amyloid-beta without concomitant T cell responses.
    Chackerian B; Rangel M; Hunter Z; Peabody DS
    Vaccine; 2006 Sep; 24(37-39):6321-31. PubMed ID: 16806604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A peptide prime-DNA boost immunization protocol provides significant benefits as a new generation Aβ42 DNA vaccine for Alzheimer disease.
    Lambracht-Washington D; Qu BX; Fu M; Anderson LD; Eagar TN; Stüve O; Rosenberg RN
    J Neuroimmunol; 2013 Jan; 254(1-2):63-8. PubMed ID: 23036592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.